140 related articles for article (PubMed ID: 11600127)
1. Elevated in vivo frequencies of mutant T cells with altered functional expression of the T-cell receptor or hypoxanthine phosphoribosyltransferase genes in p53-deficient mice.
Suzuki T; Kusunoki Y; Tsuyama N; Ohnishi H; Seyama T; Kyoizumi S
Mutat Res; 2001 Nov; 483(1-2):13-7. PubMed ID: 11600127
[TBL] [Abstract][Full Text] [Related]
2. Hprt mutant frequency and p53 gene status in mice chronically exposed by inhalation to benzene.
Albertini RJ; Judice SA; Recio L; Walker VE
Chem Biol Interact; 2010 Mar; 184(1-2):77-85. PubMed ID: 20035728
[TBL] [Abstract][Full Text] [Related]
3. Molecular analyses of in vivo hypoxanthine-guanine phosphoribosyltransferase mutations in human T-lymphocytes: II. Demonstration of a clonal amplification of hprt mutant T-lymphocytes in vivo.
Nicklas JA; O'Neill JP; Sullivan LM; Hunter TC; Allegretta M; Chastenay BF; Libbus BL; Albertini RJ
Environ Mol Mutagen; 1988; 12(3):271-84. PubMed ID: 3262508
[TBL] [Abstract][Full Text] [Related]
4. In vivo mutant frequency of thioguanine-resistant T-cells in the peripheral blood and lymph nodes of melanoma patients.
Albertini MR; King DM; Newton MA; Vacek PM
Mutat Res; 2001 May; 476(1-2):83-97. PubMed ID: 11336986
[TBL] [Abstract][Full Text] [Related]
5. Measurement of mutant frequency in T-cell receptor (TCR) gene by flow cytometry after X-irradiation on EL-4 mice lymphoma cells.
Kunugita N; Mei N; Goncharova T; Norimura T
J Toxicol Sci; 2007 Oct; 32(4):377-86. PubMed ID: 17965552
[TBL] [Abstract][Full Text] [Related]
6. Hypoxanthine-guanine phosphoribosyltransferase reporter gene mutation for analysis of in vivo clonal amplification in patients with HTLV type 1-associated Myelopathy/Tropical spastic paraparesis.
Albertini RJ; Ardell SK; Judice SA; Jacobson S; Allegretta M
AIDS Res Hum Retroviruses; 2000 Nov; 16(16):1747-52. PubMed ID: 11080821
[TBL] [Abstract][Full Text] [Related]
7. In vivo mutagenicity of ethylene oxide at the hprt locus in T-lymphocytes of B6C3F1 lacI transgenic mice following inhalation exposure.
Walker VE; Sisk SC; Upton PB; Wong BA; Recio L
Mutat Res; 1997 Aug; 392(3):211-22. PubMed ID: 9294020
[TBL] [Abstract][Full Text] [Related]
8. Use of T-cell receptor gene probes to quantify the in vivo hprt mutations in human T-lymphocytes.
Nicklas JA; O'Neill JP; Albertini RJ
Mutat Res; 1986 Jan; 173(1):67-72. PubMed ID: 3001517
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers of styrene exposure in lamination workers: levels of O6-guanine DNA adducts, DNA strand breaks and mutant frequencies in the hypoxanthine guanine phosphoribosyltransferase gene in T-lymphocytes.
Vodicka P; Bastlová T; Vodicková L; Peterková K; Lambert B; Hemminki K
Carcinogenesis; 1995 Jul; 16(7):1473-81. PubMed ID: 7614680
[TBL] [Abstract][Full Text] [Related]
10. Molecular analyses of in vivo hprt mutations in human T-lymphocytes. I. Studies of low frequency 'spontaneous' mutants by Southern blots.
Nicklas JA; Hunter TC; Sullivan LM; Berman JK; O'Neill JP; Albertini RJ
Mutagenesis; 1987 Sep; 2(5):341-7. PubMed ID: 3325766
[TBL] [Abstract][Full Text] [Related]
11. 1,3-butadiene: cancer, mutations, and adducts. Part III: In vivo mutation of the endogenous hprt genes of mice and rats by 1,3-butadiene and its metabolites.
Walker VE; Meng Q
Res Rep Health Eff Inst; 2000 Mar; (92):89-139; discussion 141-9. PubMed ID: 10925840
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the mutagenic potency of 1,3-butadiene at the hprt locus of T-lymphocytes following inhalation exposure of female B6C3F1 mice and F344 rats.
Meng Q; Recio L; Reilly AA; Wong BA; Bauer M; Walker VE
Carcinogenesis; 1998 Jun; 19(6):1019-27. PubMed ID: 9667740
[TBL] [Abstract][Full Text] [Related]
13. Relationships between exposure, cell loss and proliferation, and manifestation of Hprt mutant T cells following treatment of preweanling, weanling, and adult male mice with N-ethyl-N-nitrosourea.
Walker VE; Jones IM; Crippen TL; Meng Q; Walker DM; Bauer MJ; Reilly AA; Tates AD; Nakamura J; Upton PB; Skopek TR
Mutat Res; 1999 Dec; 431(2):371-88. PubMed ID: 10636002
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of mutant frequencies at the hprt and the T-cell receptor loci in pediatric cancer patients before treatment.
Sawada M; Kubota M; Lin YW; Watanabe K; Koishi S; Usami I; Akiyama Y; Matsumura T; Furusho K
Mutat Res; 1998 Feb; 397(2):337-43. PubMed ID: 9541658
[TBL] [Abstract][Full Text] [Related]
15. Southern blot analysis of T-cell receptor gene rearrangements in cynomolgus monkeys, and identification of a progenitor cell HPRT mutation.
Mattano SS; Zimmer DM; Harbach PR; Hunter TC; Aaron CS
Environ Mol Mutagen; 1995; 26(2):119-26. PubMed ID: 7556108
[TBL] [Abstract][Full Text] [Related]
16. A new T-lymphocyte cloning assay for detection of in vivo mutations in the human hypoxanthine-guanine phosphoribosyltransferase gene.
Uematsu K; Yasuda J; Sekine T; Sugano K; Kudoh S; Sekiya T
Environ Mol Mutagen; 1997; 30(1):31-9. PubMed ID: 9258327
[TBL] [Abstract][Full Text] [Related]
17. Southern-blot analyses of human T-lymphocyte mutants induced in vitro by gamma-irradiation.
O'Neill JP; Hunter TC; Sullivan LM; Nicklas JA; Albertini RJ
Mutat Res; 1990 Feb; 240(2):143-9. PubMed ID: 2153929
[TBL] [Abstract][Full Text] [Related]
18. Genetic instability in human T-lymphocytes.
Albertini RJ; Nicklas JA; Skopek TR; Recio L; O'Neill JP
Mutat Res; 1998 May; 400(1-2):381-9. PubMed ID: 9685698
[TBL] [Abstract][Full Text] [Related]
19. Frequency and spectrum of ethylnitrosourea-induced mutation at the hprt and lacI loci in splenic lymphocytes of exposed lacI transgenic mice.
Walker VE; Gorelick NJ; Andrews JL; Craft TR; deBoer JG; Glickman BW; Skopek TR
Cancer Res; 1996 Oct; 56(20):4654-61. PubMed ID: 8840980
[TBL] [Abstract][Full Text] [Related]
20. Molecular analyses of in vivo hprt mutations in human T-lymphocytes: IV. Studies in newborns.
McGinniss MJ; Nicklas JA; Albertini RJ
Environ Mol Mutagen; 1989; 14(4):229-37. PubMed ID: 2583130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
